
VectivBio taken over in $1bn acquisition
VectivBio Holding AG has entered into a acquisition agreement with Ironwood Pharmaceuticals Inc. Ironwood will launch a tender offer to buy...

Vitestro raises €12m in Series A financing
California-based Sonder Capital led the Series A financing round alongside existing investors and new private investors. According to...

Genmab and argenx combine antibody know-how
Genmab A/S and argenx will start their collaboration jointly launching two antibody programmes in immunology and oncology with the...

Hot of the press: new issue of BIOTECH Insight
The current issue of the BIOTECH Insight Newsletter, launched in December 2021 by Deutsche Börse with support of BIOCOM AG, addresses hot topics in...

Tay Therapeutics in licensing deal with VYNE Therapeutics
Tay Therapeutics Ltd’s exclusive license deal with VYNE Therapeutics Inc. on the oral BET inhibitor, TAY-B2 (now known as VYN201) forsees an upfront...

EU to decarbonise aviation sector through green fuel targets
So far, SAF have been produced in tiny quantities and are far more expensive than kerosene.According to European Commissions draft regulation, fuel...

Medigene licences CD40L-CD28 costimulatory switch receptor
Medigene has licences the global exclusive rights for CD40L-CD28 costimulatory switch receptor from the Helmholtz Centre Munich. Financial details...